Literature DB >> 34344326

Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study.

Suyu Wang1, Yue Yu1, Wenting Xu2,3, Xin Lv3, Yufeng Zhang4, Meiyun Liu5.   

Abstract

BACKGROUND: The prognostic roles of three lymph node classifications, number of positive lymph nodes (NPLN), log odds of positive lymph nodes (LODDS), and lymph node ratio (LNR) in lung adenocarcinoma are unclear. We aim to find the classification with the strongest predictive power and combine it with the American Joint Committee on Cancer (AJCC) 8th TNM stage to establish an optimal prognostic nomogram.
METHODS: 25,005 patients with T1-4N0-2M0 lung adenocarcinoma after surgery between 2004 to 2016 from the Surveillance, Epidemiology, and End Results database were included. The study cohort was divided into training cohort (13,551 patients) and external validation cohort (11,454 patients) according to different geographic region. Univariate and multivariate Cox regression analyses were performed on the training cohort to evaluate the predictive performance of NPLN (Model 1), LODDS (Model 2), LNR (Model 3) or LODDS+LNR (Model 4) respectively for cancer-specific survival and overall survival. Likelihood-ratio χ2 test, Akaike Information Criterion, Harrell concordance index, integrated discrimination improvement (IDI) and net reclassification improvement (NRI) were used to evaluate the predictive performance of the models. Nomograms were established according to the optimal models. They're put into internal validation using bootstrapping technique and external validation using calibration curves. Nomograms were compared with AJCC 8th TNM stage using decision curve analysis.
RESULTS: NPLN, LODDS and LNR were independent prognostic factors for cancer-specific survival and overall survival. LODDS+LNR (Model 4) demonstrated the highest Likelihood-ratio χ2 test, highest Harrell concordance index, and lowest Akaike Information Criterion, and IDI and NRI values suggested Model 4 had better prediction accuracy than other models. Internal and external validations showed that the nomograms combining TNM stage with LODDS+LNR were convincingly precise. Decision curve analysis suggested the nomograms performed better than AJCC 8th TNM stage in clinical practicability.
CONCLUSIONS: We constructed online nomograms for cancer-specific survival and overall survival of lung adenocarcinoma patients after surgery, which may facilitate doctors to provide highly individualized therapy.
© 2021. The Author(s).

Entities:  

Keywords:  Log odds of positive lymph nodes (LODDS); Lung adenocarcinoma; Lymph node ratio (LNR); Nomogram; SEER program

Year:  2021        PMID: 34344326     DOI: 10.1186/s12885-021-08410-6

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  28 in total

1.  Log odds of positive lymph nodes as a novel prognostic indicator in NSCLC staging.

Authors:  Dariusz Dziedzic; Rudzinski Piotr; Renata Langfort; Tadeusz Orlowski
Journal:  Surg Oncol       Date:  2017-02-01       Impact factor: 3.279

2.  The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients.

Authors:  Bing-Yen Wang; Jing-Yang Huang; Heng-Chung Chen; Ching-Hsiung Lin; Sheng-Hao Lin; Wei-Heng Hung; Ya-Fu Cheng
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-08       Impact factor: 4.553

Review 3.  Abandoning the Notion of Non-Small Cell Lung Cancer.

Authors:  Valeria Relli; Marco Trerotola; Emanuela Guerra; Saverio Alberti
Journal:  Trends Mol Med       Date:  2019-05-30       Impact factor: 11.951

4.  Lung Adenocarcinoma has a Higher Risk of Lymph Node Metastasis than Squamous Cell Carcinoma: A Propensity Score-Matched Analysis.

Authors:  Han-Yu Deng; Miao Zeng; Gang Li; Guha Alai; Jun Luo; Lun-Xu Liu; Qinghua Zhou; Yi-Dan Lin
Journal:  World J Surg       Date:  2019-03       Impact factor: 3.352

Review 5.  Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review.

Authors:  Kathryn C Arbour; Gregory J Riely
Journal:  JAMA       Date:  2019-08-27       Impact factor: 56.272

6.  The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.

Authors:  Fanlu Meng; Linlin Zhang; Yaoyao Ren; Qing Ma
Journal:  J Cell Physiol       Date:  2018-12-13       Impact factor: 6.384

7.  Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer.

Authors:  Weiye Deng; Ting Xu; Yifan Wang; Yujin Xu; Pei Yang; Daniel Gomez; Zhongxing Liao
Journal:  Lung Cancer       Date:  2018-05-23       Impact factor: 5.705

8.  RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma.

Authors:  Chengdi Wang; Shuangyan Tan; Wen-Rong Liu; Qian Lei; Wenliang Qiao; Yangping Wu; Xiaoqi Liu; Wei Cheng; Yu-Quan Wei; Yong Peng; Weimin Li
Journal:  Mol Cancer       Date:  2019-09-04       Impact factor: 27.401

9.  Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer.

Authors:  Ali Riaz Baqar; Simon Wilkins; Wei Wang; Karen Oliva; Paul McMurrick
Journal:  BMC Cancer       Date:  2020-08-14       Impact factor: 4.430

View more
  4 in total

1.  Role of Pneumonectomy in T1-4N2M0 Non-Small Cell Lung Cancer: A Propensity Score Matching Analysis.

Authors:  Suyu Wang; Qing Wang; Wanli Zhu; Juan Wei; Di Feng; Xin Lv; Meiyun Liu
Journal:  Front Oncol       Date:  2022-06-20       Impact factor: 5.738

2.  Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: a SEER cohort-based study.

Authors:  Qing Wang; Suyu Wang; Zhiyong Sun; Min Cao; Xiaojing Zhao
Journal:  BMC Cancer       Date:  2022-07-20       Impact factor: 4.638

3.  Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort.

Authors:  Qing Wang; Yansu Wang; Xinyu Wang; Yusuke Nakamura; Per Hydbring; Yoshikane Yamauchi; Xiaojing Zhao; Min Cao
Journal:  Transl Lung Cancer Res       Date:  2022-08

4.  Construction and validation of nomograms based on the log odds of positive lymph nodes to predict the prognosis of lung neuroendocrine tumors.

Authors:  Suyu Wang; Juan Wei; Yibin Guo; Qiumeng Xu; Xin Lv; Yue Yu; Meiyun Liu
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.